Freudenheim Partners represents Ketryx in 10,222 s/f sublease at One Main St., Cambridge, MA

Cambridge, MA Freudenheim Partners represented Ketryx, one of the leaders in AI-native compliance for life sciences, in securing a 10,222 s/f sublease at One Main St. Fresh off of announcing the company’s $39 million Series B, the new space will support Ketryx’s growing Boston-area operations and plans to hire additional employees as demand for its advanced compliance technology accelerates.

Chris Rogers and Ellie Cullinan of Freudenheim Partners represented Ketryx, while David Townsend of Newmark represented the sublandlord, Mass. General Brigham.

This location ensures Ketryx remains at the center of the city’s innovation ecosystem, offering proximity to top tech talent, research institutions, and venture partners. The move demonstrates Ketryx’s commitment to building a best-in-class team and delivering intelligent, AI-driven compliance solutions to regulated sectors like medical devices and pharmaceuticals.

“Ketryx is at an exciting inflection point, scaling its team and operations to meet strong market demand,” said both Cullinan and Rogers. “We’re proud to have helped them secure a premier location in Cambridge that will support their growth and innovation goals.”

Founded by CEO Erez Kaminski, Ketryx is an AI-native compliance platform designed to help life science teams release safer products faster.

The company, which is relocating from its previous space at the Cambridge Innovation Center, has a100 employees globally, with 50 based in the city.

Ketryx’s new office at One Main St. gives us room to grow and places us at the center of the life sciences community, making it easier to collaborate and help our partners build AI in regulated environments,” said Kaminski. “Freudenheim Partners helped us find a space that reflects our ambition and supports the kind of work we believe in: practical, high-trust innovation that can scale.”

Ketryx also plans to use the new space to host customers and partners, and educational events focused on the role of AI in healthcare and regulated industries, further integrating with the Kendall Square community.